CoChat

Assessing availability, prices, and market share of quality-assured malaria ACT and RDT in the private retail sector in Nigeria and Uganda

Open access

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

Background: An estimated 50% of suspected malaria cases in sub-Saharan Africa first seek care in the private sector, especially in private medicine retail outlets. Quality of care in these outlets is generally unknown but considered poor with many patients not receiving a confirmatory diagnosis or the recommended first-line artemisinin-based combination therapy (ACT). In 2010, a subsidy pilot scheme, the Affordable Medicines Facility malaria, was introduced to crowd out the use of monotherapies in favour of WHO-pre-qualified artemisinin-based combinations (WHO-PQ-ACTs) in the private health sector. The scheme improved the availability, market share, and cost of WHO-PQ-ACTs in countries like Nigeria and Uganda, but in 2018, the subsidies were halted in Nigeria and significantly reduced in Uganda. This paper presents findings from six retail audit surveys conducted from 2014 to 2021 in Nigeria and Uganda to assess whether the impact of subsidies on the price, availability, and market share of artemisinin-based combinations has been sustained after the subsidies were reduced or discontinued. Methods: Six independent retail audits were conducted in private medicine retail outlets, including pharmacies, drug shops, and clinics in Nigeria (2016, 2018, 2021), and Uganda (2014, 2019, 2020) to assess the availability, price, and market share of anti-malarials, including WHO-PQ-ACTs and non-WHO-PQ-ACTs, and malaria rapid diagnostic tests (RDTs). Results: Between 2016 and 2021, there was a 57% decrease in WHO-PQ-ACT availability in Nigeria and a 9% decrease in Uganda. During the same period, non-WHO-PQ-ACT availability increased in Nigeria by 41% and by 34% in Uganda. The price of WHO-PQ-ACTs increased by 42% in Nigeria to $0.68 and increased in Uganda by 24% to $0.95. The price of non-WHO-PQ-ACTs decreased in Nigeria by 26% to $1.08 and decreased in Uganda by 64% to $1.23. There was a 76% decrease in the market share of WHO-PQ-ACTs in Nigeria and a 17% decrease in Uganda. Malaria RDT availability remained low throughout. Conclusion: With the reduction or termination of subsidies for WHO-PQ-ACTs in Uganda and Nigeria, retail prices have increased, and retail prices of non-WHO-PQ-ACTs decreased, likely contributing to a shift of higher availability and increased use of non-WHO-PQ-ACTs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12936-024-04863-9

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Availability of WHO-PQ-ACTs in Nigeria and Uganda 2014–2021
Fig. 1 Availability of WHO-PQ-ACTs in Nigeria and Uganda 2014–2021CC BY · PubMed Central
Fig. 2 Availability of Non-WHO-PQ-ACTs in Nigeria and Uganda 2014–2021
Fig. 2 Availability of Non-WHO-PQ-ACTs in Nigeria and Uganda 2014–2021CC BY · PubMed Central
Fig. 3 Average Retail Price of WHO-PQ-ACTs in Nigeria and Uganda 2014–2021
Fig. 3 Average Retail Price of WHO-PQ-ACTs in Nigeria and Uganda 2014–2021CC BY · PubMed Central
Fig. 4 Average Retail Price of non-WHO-PQ-ACTs in Nigeria and Uganda 2014–2021
Fig. 4 Average Retail Price of non-WHO-PQ-ACTs in Nigeria and Uganda 2014–2021CC BY · PubMed Central
Fig. 5 Market share of WHO-PQ-ACTs among ACTs sold in Nigeria and Uganda 2014–2021
Fig. 5 Market share of WHO-PQ-ACTs among ACTs sold in Nigeria and Uganda 2014–2021CC BY · PubMed Central
Fig. 6 Market share of WHO-PQ-ACTs among all antimalarials sold in Nigeria and Uganda 2018–2021
Fig. 6 Market share of WHO-PQ-ACTs among all antimalarials sold in Nigeria and Uganda 2018–2021CC BY · PubMed Central
Fig. 7 RDT Availability in Nigeria and Uganda 2016–2021
Fig. 7 RDT Availability in Nigeria and Uganda 2016–2021CC BY · PubMed Central
Fig. 8 RDT Prices in Nigeria and Uganda 2016–2021
Fig. 8 RDT Prices in Nigeria and Uganda 2016–2021CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Research works printed but not linked: 1

  1. Oladosu OO, Oyibo WA, Bachani D, Hazir T, Ramharter M, Remoue F, et al. Overdiagnosis and overtreatment of malaria in children that presented with fever in Lagos. Nigeria ISRN Infect Dis. 2013;2013: 914675.

Cited by

See all 9

Metadata

Authors
Woldeghebriel, M., Aso, E., Berlin, E., Fashanu, C., Kirumira, S. N., Lam, F., Mugerwa, R., Nakiganda, J., Olaleye, T., Opigo, J., Osinupebi, F., Priestley, N., Stringham, R., Uhomoibhi, P., Visser, T., Ward, A., Wiwa, O., & Woolsey, A.
Affiliations
  • Clinton Health Access Initiative (US)
  • Ministry of Health (UG)
  • Virginia Commonwealth University (US)
  • Federal Ministry of Health (NG)
Corresponding author
Woldeghebriel, Meley
Venue
Malaria Journal
Published
2024-02-06
Volume
23
Issue
1
Pages
41-41
ISSN
1475-2875 (ISSN-L)
OpenAlex
W4391564914
Cited by
9
References
21
Citations by year
2026: 2 · 2025: 6 · 2024: 1
FWCI
3.19
Type
journal article
Language
en
Open access
Licence
Locations
  • Malaria Journal (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
Foreign Commonwealth and Development Office (FCDO) of the UK Government
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pharmaceutical Quality and Counterfeiting
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
Keywords
artemisinin-based combination therapy, malaria rapid diagnostic tests, Affordable Medicines Facility-malaria, drug subsidies, drug availability, drug prices, market share, malaria treatment, Nigeria, Uganda, drug policy evaluation
MeSH terms
Antimalarials, Humans, Malaria, Nigeria, Uganda, Private Sector, Artemisinins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Assessing availability, prices, and market share of quality-assured malaria ACT and RDT in the private retail sector in Nigeria and Uganda. https://app.cochat.ai/papers/10.1186/s12936-024-04863-9
The paper
Woldeghebriel, M., Aso, E., Berlin, E., Fashanu, C., Kirumira, S. N., Lam, F., Mugerwa, R., Nakiganda, J., Olaleye, T., Opigo, J., Osinupebi, F., Priestley, N., Stringham, R., Uhomoibhi, P., Visser, T., Ward, A., Wiwa, O., & Woolsey, A. (2024). Assessing availability, prices, and market share of quality-assured malaria ACT and RDT in the private retail sector in Nigeria and Uganda. Malaria Journal. https://doi.org/10.1186/s12936-024-04863-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.